[1]王 璠.不同结局血液透析患者中医证型差异研究[J].医学信息,2021,34(16):178-180.[doi:10.3969/j.issn.1006-1959.2021.16.051]
　Wang Fan.Study on the Difference of TCM Syndrome Types in Hemodialysis Patients with Different Outcomes[J].Medical Information,2021,34(16):178-180.[doi:10.3969/j.issn.1006-1959.2021.16.051]
点击复制

不同结局血液透析患者中医证型差异研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年16期
页码:
178-180
栏目:
中医中药
出版日期:
2021-08-15

文章信息/Info

Title:
Study on the Difference of TCM Syndrome Types in Hemodialysis Patients with Different Outcomes
文章编号:
1006-1959（2021）16-0178-03
作者:
王 璠
（天津市和平区中医医院血液透析室，天津 300020）
Author(s):
Wang Fan
(Hemodialysis Room, Heping District Hospital of Traditional Chinese Medicine, Tianjin 300020)
关键词:
血液透析; 慢性肾功能衰竭; 中医证型
Keywords:
Hemodialysis; Chronic kidney failure; TCM Syndrome type
分类号:
R692.5
DOI:
10.3969/j.issn.1006-1959.2021.16.051
文献标志码:
A
摘要:
目的 研究血液透析患者的中医证型特点，为临床提高慢性肾功能衰竭生存质量提供一定的参考依据。方法 回顾性分析2000年1月~2020年1月在北京市东方医院及天津市和平区中医医院血液透析中心接受血液透析治疗死亡（n=55）及同期维持性血液透析存活（n=55例）的患者临床资料，分别作为死亡组和存活组，对两组患者进行中医辨证分型，比较两组中医证型分布特征及死亡率。结果 死亡组中虚实夹杂证候发生率最高，为72.72%，单纯虚证为21.57%、单纯实证为7.27%，其中虚证中脾肾气虚最高（43.13%），实证中湿浊最高（66.59%）；两组证型分布比较，差异无统计意义（P＞0.05），阴阳两虚型死亡率最高（75.00%），其余从高到低依次为气阴两虚、脾肾阳虚、脾肾气虚；两组各证型分布比较，差异无统计意义（P＞0.05），血瘀死亡率最高（62.50%），其余从高到低依次为湿浊、湿热。结论 血液透析死亡患者中医证型以虚实夹杂、单纯虚证为主，虚证中以脾肾气虚为主，实证中以湿浊为主。虚证中死亡率最低脾肾气虚，提示脾肾气虚患者透析较为充分，阴阳两虚型透析充分性较差，死亡率最高。临床对于血液透析患者，应给予辨证论治干预，如补肾益气、补肾健脾治疗，以改善患者中医证型，进一步促进血液透析的充分性，降低血液透析患者的死亡率，提高血压透析患者的生存质量。
Abstract:
Objective To study the characteristics of TCM Syndrome types in hemodialysis patients with death, and to provide a basis for improving the quality of life of chronic kidney failure.Method The clinical data of patients who died of hemodialysis (n=55) and survived maintenance hemodialysis (n=55) in Beijing Dongfang Hospital and the hemodialysis center of Tianjin Heping District traditional Chinese medicine hospital from January 2000 to January 2020 were retrospectively analyzed. The two groups were divided into death group and survival group, The distribution characteristics of TCM Syndrome Types and mortality were compared between the two groups.Results In the death group, the incidence of mixed syndrome of deficiency and excess was the highest, 72.72%, that of simple deficiency was 21.57%, and that of simple demonstration was 7.27%. Among them, deficiency of spleen and Kidney Qi was the highest (43.13%), and dampness and turbidity was the highest (66.59%); There was no statistical difference in the distribution of syndrome types between the two groups (P>0.05). The mortality of Yin-Yang deficiency type was the highest (75.00%), and the rest were Qi and yin deficiency, spleen and kidney yang deficiency and spleen and kidney qi deficiency from high to low; There was no significant difference in the distribution of syndrome types between the two groups (P>0.05). The mortality of blood stasis was the highest (62.50%), and the rest were dampness turbidity and dampness heat from high to low.Conclusion The TCM syndrome types of hemodialysis dead patients are mainly deficiency and excess mixed with simple deficiency syndrome, deficiency syndrome is mainly spleen and kidney qi deficiency, and dampness and turbidity are mainly in evidence. Deficiency syndrome has the lowest mortality, spleen and kidney qi deficiency, suggesting that patients with spleen and kidney qi deficiency have more adequate dialysis, and the deficiency of yin and Yang has poor dialysis adequacy and the highest mortality. Clinically, hemodialysis patients should be given syndrome differentiation and treatment intervention, such as tonifying the kidney and Qi, tonifying the kidney and strengthening the spleen, so as to improve the TCM syndrome types of patients, further promote the adequacy of hemodialysis, prevent and reduce the incidence of hemodialysis mortality, and improve the quality of life of blood pressure dialysis patients.

参考文献/References:

[1]刘香红,杨晨,肖敬玲,等.120例终末期肾脏病维持性血液透析患者中医证候规律分析[J].中国中医基础医学杂志,2015,20(2):218-219,227. [2]董丽洁.终末期肾脏病（ESRD）维持性血液透析患者的中医证候分析[J].中国医院药学杂志,2018,11(6):1-4. [3]马地那,钟剑,曹钋.155例CRF尿毒症期透析患者中医证候的调查研究[J].中国中西医结合肾病杂志,2015,15(7):605-607. [4]张太君,张玲.90例血液透析患者中医证候分布规律分析[J].世界中西医结合杂志,2015,10(2):207-209. [5]马雷雷,曹钋,赵虎康,等.单中心血液透析患者透析时机回顾性研究[J].中国中西医结合肾病杂志,2016,17(10):892-894. [6]Luan W,Liu Y,Jiang Al,et al.Nursing Based on Syndrome Differentiation Combined with Auricular Plaster Therapy in Alleviating Insomnia[J].J Integr Nurs,2019,1(1):35-40. [7]张晓华,李静,王利华.维持性血液透析患者的长期生存分析[J].中国血液净化,2019,18(12):826-829. [8]黄春霞,许宝珠,林花兰,等.维持性血液透析患者生活质量及危险因素分析[J].海南医学,2017,28(21):3543-3544. [9]闵永龙.维持性血液透析患者疲劳度与中医证型的关系及影响因素分析[D].长沙:湖北中医药大学,2019. [10]Zhang CH,Yu CG,Li PY,et al.Research Status of Traditional Chinese Medicine Constitution Theory in Insomnia[J].J Integr Nurs,2019,1(1):51-58． [11]赵万超,远方.辽宁地区523例慢性肾衰竭患者中医证型特征分析[J].云南中医中药杂志,2015,36(3):21-23. [12]毛东东,熊飞,张燕敏,等.单中心440例维持性血透患者中医证候分布规律及相关性因素分析[J].中国中西医结合肾病杂志,2018,19(3):247-250. [13]Wu Y,Yang L,Li L,et al.Auricular acupressure for insomnia in hemodialysis patients: study protocol for a randomizedcontrolled trial[J].Trials,2018,19(1):171. [14]方建,秦海峰.糖尿病肾病维持性血液透析患者生存质量及相关因素研究[J].中国中西医结合肾病杂志,2019,20(4):313-315. [15]孙明继,赵新菊,唐盛,等.维持性血液透析死亡患者相关信息及贫血治疗情况的多中心回顾性分析[J].中国血液净化,2019,18(9):618-621.

相似文献/References:

[1]肖一红.组合型人工肾技术预防血液透析中低血压的效果观察[J].医学信息,2018,31(03):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
　XIAO Yi-hong.Effect of Combined Artificial Renal Technique in Preventing Hypotension in Hemodialysis[J].Medical Information,2018,31(16):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
[2]邹 鑫,刘秀娟,余燕燕.血液透析对MHD患者血清FGF-23水平与 钙磷代谢的影响[J].医学信息,2018,31(09):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
　ZOU Xin,LIU Xiu-juan,YU Yan-yan.Effect of Hemodialysis on Serum FGF-23 Level and Calcium and Phosphorus Metabolism in MHD Patients[J].Medical Information,2018,31(16):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
[3]王允彦.西那卡塞对维持性血液透析继发性甲状旁腺功能亢进患者FGF-23的影响[J].医学信息,2018,31(13):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
　WANG Yun-yan.Effect of Cinacalcet on FGF-23 in Patients with Secondary Hyperparathyroidism during Maintenance Hemodialysis[J].Medical Information,2018,31(16):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
[4]蒋红利,刘 华,史珂慧,等.陕西省县级医院透析室建设项目培训效果评价[J].医学信息,2018,31(19):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
　JIANG Hong-li,LIU Hua,SHI Ke-hui,et al.Evaluation on Training Effect of Dialysis Room Construction Project in County Hospitals in Shaanxi Province[J].Medical Information,2018,31(16):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
[5]郭 婵.前列地尔对慢性肾功能衰竭患者血清炎症因子水平及营养生化指标的影响[J].医学信息,2022,35(13):146.[doi:10.3969/j.issn.1006-1959.2022.13.035]
　GUO Chan.Effect of Alprostadil on Serum Inflammatory Factors and Nutritional Biochemical Indexes in Patients with Chronic Renal Failure[J].Medical Information,2022,35(16):146.[doi:10.3969/j.issn.1006-1959.2022.13.035]
[6]张丽华,张坪兰.焦点式心理护理对慢性肾功能衰竭患者日常生活能力及满意度的影响[J].医学信息,2022,35(13):190.[doi:10.3969/j.issn.1006-1959.2022.13.048]
　ZHANG Li-hua,ZHANG Ping-lan.Effect of Focus Psychological Nursing on Daily Living Ability and Satisfaction of Patients with Chronic Renal Failure[J].Medical Information,2022,35(16):190.[doi:10.3969/j.issn.1006-1959.2022.13.048]
[7]张民霞.血液灌流联合血液透析治疗肾功能衰竭难治性高血压的效果[J].医学信息,2019,32(15):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
　ZHANG Min-xia.Effect of Hemoperfusion Combined with Hemodialysis on Refractory Hypertension with Renal Failure[J].Medical Information,2019,32(16):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
[8]谢 华,周毅峰,甘晓庆,等.血液透析专用中心静脉导管封管液的研究[J].医学信息,2019,32(18):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
　XIE Hua,ZHOU Yi-feng,GAN Xiao-qing,et al.Research on Central Venous Catheter Sealing Fluid for Hemodialysis[J].Medical Information,2019,32(16):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
[9]喻学娜.协同护理对终末期肾脏病血液透析患者自我护理能力及治疗依从性的影响[J].医学信息,2019,32(20):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
　YU Xue-na.Effect of Collaborative Nursing on Self-care Ability and Treatment Compliance of Hemodialysis Patients with End-stage Renal Disease[J].Medical Information,2019,32(16):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
[10]魏昌林.血液透析联合血液灌流在终末期肾病患者治疗中的应用[J].医学信息,2019,32(13):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
　WEI Chang-lin.Application of Hemodialysis Combined with Blood Perfusion in the Treatment of Patients with End-stage Renal Disease[J].Medical Information,2019,32(16):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
[11]方海东,李 荣.血液透析滤过联合血液透析治疗慢性肾功能衰竭的效果观察[J].医学信息,2019,32(02):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
　FANG Hai-dong,LI Rong.Effect of Hemodiafiltration Combined with Hemodialysis on Chronic Renal Failure[J].Medical Information,2019,32(16):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
[12]刘菲菲.慢性肾功能衰竭患者血液透析护理中的危险因素分析及护理对策[J].医学信息,2020,33(24):169.[doi:10.3969/j.issn.1006-1959.2020.24.049]
　LIU Fei-fei.Analysis of Risk Factors in Hemodialysis Nursing of Patients with Chronic Renal Failure and Nursing Countermeasures[J].Medical Information,2020,33(16):169.[doi:10.3969/j.issn.1006-1959.2020.24.049]
[13]全 红,唐玉娟,王 然.血清TNF-α、CRP、IL-6指标在慢性肾功能衰竭患者中的检验价值分析[J].医学信息,2023,36(09):128.[doi:10.3969/j.issn.1006-1959.2023.09.026]
　QUAN Hong,TANG Yu-juan,WANG Ran.Analysis of the Test Value of Serum TNF-α,CRP and IL-6 in Patients with Chronic Renal Failure[J].Medical Information,2023,36(16):128.[doi:10.3969/j.issn.1006-1959.2023.09.026]

更新日期/Last Update: 1900-01-01